Immunodominant human T-cell epitopes of hepatitis C virus
US6689368B1 · kind B1 · utility
3Cited by
9References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1997 |
| Grant date | Feb 10, 2004 |
| Priority date | — |
| Expiry date | Nov 19, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a polypeptide of about 8 to about 100 amino acids comprising or consisting of at least 8 contiguous amino acids selected from the core, and/or the NS3 regions of the HCV polyprotein, with said contiguous amino acids containing a T-cell stimulating epitope.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.